254 related articles for article (PubMed ID: 38140059)
1. Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles.
Hba S; Ghaddar S; Wahnou H; Pinon A; El Kebbaj R; Pouget C; Sol V; Liagre B; Oudghiri M; Limami Y
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140059
[TBL] [Abstract][Full Text] [Related]
2. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
Malla RR; Siragam S; Dadi V; Seetini B
Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
[TBL] [Abstract][Full Text] [Related]
3. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
4. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
5. Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors.
George G; Koyiparambath VP; Sukumaran S; Nair AS; Pappachan LK; Al-Sehemi AG; Kim H; Mathew B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328542
[TBL] [Abstract][Full Text] [Related]
6. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development.
Xu S; Chen M; Chen W; Hui J; Ji J; Hu S; Zhou J; Wang Y; Liang G
BMC Cancer; 2015 Nov; 15():870. PubMed ID: 26552551
[TBL] [Abstract][Full Text] [Related]
8. Algae-Derived Natural Products in Diabetes and Its Complications-Current Advances and Future Prospects.
Pereira L; Valado A
Life (Basel); 2023 Aug; 13(9):. PubMed ID: 37763235
[TBL] [Abstract][Full Text] [Related]
9. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.
Salehi B; Quispe C; Chamkhi I; El Omari N; Balahbib A; Sharifi-Rad J; Bouyahya A; Akram M; Iqbal M; Docea AO; Caruntu C; Leyva-Gómez G; Dey A; Martorell M; Calina D; López V; Les F
Front Pharmacol; 2020; 11():592654. PubMed ID: 33536909
[TBL] [Abstract][Full Text] [Related]
11. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.
Malla R; Viswanathan S; Makena S; Kapoor S; Verma D; Raju AA; Dunna M; Muniraj N
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672545
[TBL] [Abstract][Full Text] [Related]
12. Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
[TBL] [Abstract][Full Text] [Related]
13. Potentiating activity of Norfloxacin by synthetic chalcones against NorA overproducing Staphylococcus aureus.
Alves Borges Leal AL; Teixeira da Silva P; Nunes da Rocha M; Marinho EM; Marinho ES; Marinho MM; Bandeira PN; Sampaio Nogueira CE; Barreto HM; Rodrigues Teixeira AM; Silva Dos Santos H
Microb Pathog; 2021 Jun; 155():104894. PubMed ID: 33894291
[TBL] [Abstract][Full Text] [Related]
14. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
15. Chalcones: Potential Chemotherapeutic Compounds and Educational Tools for Closing the Loop in STEM.
Russell AE; Gines BR
Acc Chem Res; 2023 Jun; 56(11):1256-1262. PubMed ID: 36696370
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Caco-2 and MCF-7 cancer cells using chalcones: synthesis, biological evaluation and computational study.
Mellado M; Reyna-Jeldes M; Weinstein-Oppenheimer C; Coddou C; Jara-Gutierrez C; Villena J; Aguilar LF
Nat Prod Res; 2022 Sep; 36(17):4410-4416. PubMed ID: 34583595
[TBL] [Abstract][Full Text] [Related]
17. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.
Yang J; Lv J; Cheng S; Jing T; Meng T; Huo D; Ma X; Wen R
Anticancer Agents Med Chem; 2023; 23(11):1265-1283. PubMed ID: 36825723
[TBL] [Abstract][Full Text] [Related]
18. Novel Tetrahydro-[1,2,4]triazolo[3,4-
Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
[TBL] [Abstract][Full Text] [Related]
19. Natural and Synthetic Chalcones: Potential Impact on Breast Cancer.
Dadi V; Malla RR; Siragam S
Crit Rev Oncog; 2023; 28(4):27-40. PubMed ID: 38050979
[TBL] [Abstract][Full Text] [Related]
20. Small Multitarget Molecules Incorporating the Enone Moiety.
Liargkova T; Eleftheriadis N; Dekker F; Voulgari E; Avgoustakis C; Sagnou M; Mavroidi B; Pelecanou M; Hadjipavlou-Litina D
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
